Georgialina Rodriguez to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Georgialina Rodriguez has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.035
-
Oaxaca DM, Yang-Reid SA, Ross JA, Rodriguez G, Staniswalis JG, Kirken RA. Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Tumour Biol. 2016 Sep; 37(9):12643-12654.
Score: 0.035